Following promising clinical results, retatrutide, a novel peptide treatment for addressing type 2 metabolic disorder, has secured conditional approval from UK’s Medicines and Healthcare Agency (MHRA https://shopretatrutidepeptide.com/category/retatrutide-peptide/